Lexicon Pharmaceuticals Inc
Research Lexicon Pharmaceuticals Inc (LXRX) on Bullrun: market cap USD 1.04B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLXRX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.04B
- Financial periodQ2 2026
- RevenueUSD 692.00K
- Net income-USD 31.78M
- Free cash flow-USD 9.19M
- Gross margin94.4%
Valuation Snapshot
latest market cap is USD 1.04B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 49.80M | -USD 50.34M | -USD 67.85M | 99.4% | -0.14 | USD 34.33M | USD 54.00M | USD 107.54M |
| FY2024 | USD 6.00M | -USD 200.40M | -USD 179.81M | 89.7% | -0.63 | USD 66.66M | USD 100.30M | USD 145.95M |
| FY2023 | USD 1.11M | -USD 177.12M | -USD 162.37M | 92.3% | -0.8 | USD 22.47M | USD 99.51M | USD 93.11M |
| FY2022 | USD 0 | -USD 101.94M | -USD 90.18M | n/a | -0.62 | USD 46.35M | USD 48.58M | USD 117.12M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.04B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 417.99M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 267.50M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 373.36M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 360.47M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 586.73M | n/a | n/a | n/a |
About Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lexicon Pharmaceuticals Inc's market cap?
Lexicon Pharmaceuticals Inc's market capitalization is USD 1.04B.
What does Lexicon Pharmaceuticals Inc do?
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes.